Status:
COMPLETED
Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Bone and Joint Infection
Antibiotic Reaction
Eligibility:
All Genders
18+ years
Brief Summary
Staphyloccous aureus and coagulase negative staphylocci are responsible of a large marjority of PJI. Regarding the high rate of methicillin resistance, current guidelines recommend the use of a glycop...
Eligibility Criteria
Inclusion
- patients having had a PJI or BJI treated whith ceftaroline and/or ceftobiprole
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 5 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04409769
Start Date
February 1 2020
End Date
May 5 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004